Globe Life opens the week with a clear analyst picture, shares hold near recent highs

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 14:33.

Globe Life (US37959E1029) enters the new week with its shares trading on the NYSE close to their recent peak, according to MarketBeat price data for June 26, 2026. TD Cowen recently raised its price target on the insurer and reiterated a Buy rating, shaping the current analyst view on the stock.

What TD Cowen signals

On June 23, 2026 TD Cowen adjusted its price target for Globe Life to 215 US dollars from 199 US dollars and maintained a Buy recommendation, as reported by MarketScreener. The move points to a constructive stance on the company’s earnings and capital-return profile within the US life insurance sector, where peers include names such as MetLife and Prudential Financial.

The TD Cowen update comes after a strong year-to-date performance for Globe Life, with MarketScreener data showing the shares up around 30.8 percent since the start of the year as of June 29, 2026. This places the stock among the better performers in its insurance peer group and frames expectations ahead of the next quarterly report. MarketScreener’s analyst and insider overview provides further detail on Globe Life’s rating distribution and recent target changes.

Recent insider activity and share levels

MarketScreener highlights that an insider at Globe Life sold shares worth about 1.48 million US dollars on June 26, 2026, based on an SEC filing. Insider transactions of this magnitude are closely watched by investors as an additional data point alongside analyst research, even though a single sale does not define the broader valuation picture.

In parallel, MarketBeat quotes Globe Life shares at 179.28 US dollars at the regular NYSE close on June 26, 2026, with an after-hours indication around 179.38 US dollars. Over the past 50 days, the trading range cited by MarketBeat runs roughly between 149.76 and 179.28 US dollars, indicating that the current price is near the upper end of the recent band. A year-to-date plus of more than 30 percent as reported by MarketScreener underlines that the stock has delivered a marked advance compared with many broader indices. MarketBeat’s NYSE quote page offers additional intraday data and historical price charts for Globe Life.

The business behind the stock

Globe Life’s core business is writing life insurance and supplemental health policies for US households, particularly in the middle-income segment, through brands such as Globe Life, American Income Life and Liberty National, as described on its corporate site. The company distributes many of its policies via exclusive agencies and direct-to-consumer channels, aiming for stable underwriting margins and recurring premium income in a largely domestic footprint.

Where the shares trade today

Globe Life shares (US37959E1029) trade on the NYSE under the ticker GL, with MarketBeat quoting a last regular-session price of 179.28 US dollars as of 2026-06-26, 15:59 Eastern Time. Extended-hours trading on the same date shows a modestly higher indication around 179.38 US dollars, underscoring the stock’s position near its recent highs on the US exchange.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data are based on sources cited and may change without notice. Investors should conduct their own research or consult a qualified advisor before making investment decisions.